1. INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses. Issue 1 (18th January 2023) Authors: Sulzmaier, Florian J; Kern, Nadja; Ahn, Sae Jeong; Polovina, Anya; Ho, Jason; Hussain, Abrahim; Cyprus, Garrett; Macedo, Chelsie; Pandit, Rajay; Crago, William; Rowell, Emily; Timmer, John C; Eckelman, Brendan P Journal: Journal for immunotherapy of cancer Issue: Volume 11:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗